Literature DB >> 2528072

Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma.

D Vidović1, M Roglić, K McKune, S Guerder, C MacKay, Z Dembić.   

Abstract

Distinct T-lymphocyte subsets recognize antigens in conjunction with different classes of major histocompatibility complex (MHC) glycoproteins using the T-cell receptor (TCR), a disulphide-linked heterodimer associated with the CD3 complex on the cell surface. In general, class I and class II MHC products provide a context for the recognition of foreign antigens by CD8+ and CD4+ T cells, respectively. This recognition seems to be largely dependent on alpha beta TCR heterodimers, whereas the function of the second gamma delta TCR, present on a minor subpopulation of cells, is still unknown. In the mouse, the existence of six cell-surface MHC class I products (K, D, L, Qa-1, Qa-2 and Tla) has been firmly established by serological, biochemical and genetic evidence. So far, only the most polymorphic of them, K, D and L ('classical' class I) have been reported as restriction elements for T-cell recognition of foreign antigens. The function of the relatively invariant Qa and Tla molecules remains unknown. We have made a T-helper cell hybridoma clone (DGT3) that recognizes synthetic copolymer poly(Glu50Tyr50) in the context of Qa-1 cell surface product, and has a CD4-CD8- phenotype. Our studies indicate that DGT3 cells express the gamma delta TCR on the cell surface, implicating its role in Qa-1-restricted antigen recognition. This is the first evidence that T cells can recognize foreign antigen in association with self Qa product, confirming that Qa molecules not only topologically, but also functionally, belong to the MHC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528072     DOI: 10.1038/340646a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  81 in total

1.  The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells.

Authors:  J D Fayen; M L Tykocinski
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  Bovine gammadelta T-cell responses to the intracellular protozoan parasite Theileria parva.

Authors:  C A Daubenberger; E L Taracha; L Gaidulis; W C Davis; D J McKeever
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

4.  Expression of the thymus leukemia antigen in mouse intestinal epithelium.

Authors:  R Hershberg; P Eghtesady; B Sydora; K Brorson; H Cheroutre; R Modlin; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 5.  Epidermal T lymphocytes--ontogeny, features and function.

Authors:  E Payer; A Elbe; G Stingl
Journal:  Springer Semin Immunopathol       Date:  1992

6.  Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice.

Authors:  I Correa; M Bix; N S Liao; M Zijlstra; R Jaenisch; D Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

7.  Dual antigenic recognition by cloned human gamma delta T cells.

Authors:  J Holoshitz; L M Vila; B J Keroack; D R McKinley; N K Bayne
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 8.  Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.

Authors:  Peter E Jensen; Barbara A Sullivan; Lisa M Reed-Loisel; Dominique A Weber
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 9.  Maturation, selection and specificity of Tcr gamma delta T cells.

Authors:  L Lefrançois
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 10.  HLA non-A,B,C class I genes: their structure and expression.

Authors:  H Heinrichs; H T Orr
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.